RETA
Reata Pharmaceuticals Inc
Chief Commercial Officer Dawn Carter Bir sold $203K of Reata Pharmaceuticals Inc
Sold$203,409
$168.80Price
1,205Shares
−3%Stake
What RETA did after the filing
- The stock from Thu, Aug 17 close, $169.00
- +2.0%
- S&P 500, same days
- −0.6%
26 of 30 trading days so far, to the Sep 25 close.
Traded Tue, Aug 15. Filed Thu, Aug 17, 12:35 PM ET, during the session. Returns use the Aug 17 close and the Sep 25 close. Not investment advice.